Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck
Abhay S. Gokhale(Beth Israel Deaconess Medical Center), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Lori J. Wirth(Massachusetts General Hospital), M. Hallar(Beth Israel Deaconess Medical Center), Lisa A. Cavacini(University of Massachusetts Chan Medical School), Jarrod Faucher(Harvard University), Robert I. Haddad(Georgetown University), Linda Weeks(Dana-Farber Cancer Institute)
Cited by 71
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Structure and function of immunoglobulins
|Journal of Allergy and Clinical Immunology|2010|1.9k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926